Zentalis Pharmaceuticals (ZNTL) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $160000.0.
- Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization fell 5015.58% to $160000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $160000.0, marking a year-over-year decrease of 5015.58%. This contributed to the annual value of $1.3 million for FY2024, which is 714.29% down from last year.
- As of Q3 2025, Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization stood at $160000.0, which was down 5015.58% from $160000.0 recorded in Q2 2025.
- In the past 5 years, Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $1.4 million in Q4 2022 and a low of $160000.0 during Q2 2025
- Its 4-year average for Accumulated Depreciation & Amortization is $519933.3, with a median of $344000.0 in 2022.
- In the last 5 years, Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization soared by 465.12% in 2023 and then plummeted by 5107.03% in 2025.
- Quarter analysis of 4 years shows Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization stood at $1.4 million in 2022, then decreased by 1.82% to $1.4 million in 2023, then fell by 7.14% to $1.3 million in 2024, then plummeted by 87.69% to $160000.0 in 2025.
- Its Accumulated Depreciation & Amortization was $160000.0 in Q3 2025, compared to $160000.0 in Q2 2025 and $262000.0 in Q1 2025.